Litigation Details for AUROBINDO PHARMA LIMITED v. ASTRAZENECA AB (D.N.J. 2016)
✉ Email this page to a colleague
AUROBINDO PHARMA LIMITED v. ASTRAZENECA AB (D.N.J. 2016)
Docket | ⤷ Sign Up | Date Filed | 2016-08-18 |
Court | District Court, D. New Jersey | Date Terminated | 2017-09-21 |
Cause | 35:271 Patent Infringement | Assigned To | Peter G. Sheridan |
Jury Demand | None | Referred To | Tonianne J. Bongiovanni |
Patents | 6,403,616; 6,428,810 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in AUROBINDO PHARMA LIMITED v. ASTRAZENECA AB
Details for AUROBINDO PHARMA LIMITED v. ASTRAZENECA AB (D.N.J. 2016)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2016-08-18 | 1 | Exhibit A-D | Book”), U.S. Patent Nos. 6,403,616 (the '616 patent) and 6,428,810 (the '810 patent) are scheduled…States Patent Erickson et al. Us 6,403,616 Bi Jun. ii, 2002 (10) Patent No.: (45) Date of Patent: …2015 5,900,424 (the ‘424 patent) May 4, 2016 6,403,616 (the '616 patent) Novernber 15, 2019 6,428,810…16 Page 11 ot 27 Page|D: 35 U.S. Patent Jun. 11, 2002 US 6,403,616 B1 …1 Filed 08/18/16 Page 12 ot 27 Page|D: 36 US 6,403,616 Bl 1 CHEMICAL PROCESS AND PHARMACEUTICAL FORMUlATION | External link to document |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |